These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 16382016)

  • 1. Cellular effects of guanylin and uroguanylin.
    Sindić A; Schlatter E
    J Am Soc Nephrol; 2006 Mar; 17(3):607-16. PubMed ID: 16382016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal electrolyte effects of guanylin and uroguanylin.
    Sindić A; Schlatter E
    Curr Opin Nephrol Hypertens; 2007 Jan; 16(1):10-5. PubMed ID: 17143065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of actions of guanylin peptides in the kidney.
    Sindić A; Schlatter E
    Pflugers Arch; 2005 Aug; 450(5):283-91. PubMed ID: 15952032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guanylin and uroguanylin induce natriuresis in mice lacking guanylyl cyclase-C receptor.
    Carrithers SL; Ott CE; Hill MJ; Johnson BR; Cai W; Chang JJ; Shah RG; Sun C; Mann EA; Fonteles MC; Forte LR; Jackson BA; Giannella RA; Greenberg RN
    Kidney Int; 2004 Jan; 65(1):40-53. PubMed ID: 14675035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The proximal convoluted tubule is a target for the uroguanylin-regulated natriuretic response.
    Elitsur N; Lorenz JN; Hawkins JA; Rudolph JA; Witte D; Yang LE; McDonough AA; Cohen MB
    J Pediatr Gastroenterol Nutr; 2006 Jul; 43 Suppl 1():S74-81. PubMed ID: 16819406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uroguanylin and guanylin regulate transport of mouse cortical collecting duct independent of guanylate cyclase C.
    Sindić A; Velic A; Başoglu C; Hirsch JR; Edemir B; Kuhn M; Schlatter E
    Kidney Int; 2005 Sep; 68(3):1008-17. PubMed ID: 16105031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current understanding of guanylin peptides actions.
    Sindic A
    ISRN Nephrol; 2013; 2013():813648. PubMed ID: 24967239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pendrin, a novel transcriptional target of the uroguanylin system.
    Rozenfeld J; Tal O; Kladnitsky O; Adler L; Efrati E; Carrithers SL; Alper SL; Zelikovic I
    Cell Physiol Biochem; 2013; 32(7):221-37. PubMed ID: 24429828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guanylyl cyclase-C receptor mRNA distribution along the rat nephron.
    Carrithers SL; Taylor B; Cai WY; Johnson BR; Ott CE; Greenberg RN; Jackson BA
    Regul Pept; 2000 Nov; 95(1-3):65-74. PubMed ID: 11062334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The intestinal guanylin system and seawater adaptation in eels.
    Takei Y; Yuge S
    Gen Comp Endocrinol; 2007; 152(2-3):339-51. PubMed ID: 17561018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Guanylin and uroguanylin regulate electrolyte transport in isolated human cortical collecting ducts.
    Sindić A; Hirsch JR; Velic A; Piechota H; Schlatter E
    Kidney Int; 2005 Apr; 67(4):1420-7. PubMed ID: 15780094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of atrial natriuretic peptide, urodilatin, guanylin and uroguanylin in the isolated perfused rat kidney.
    Santos-Neto MS; Carvalho AF; Monteiro HS; Forte LR; Fonteles MC
    Regul Pept; 2006 Sep; 136(1-3):14-22. PubMed ID: 16814407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uroguanylin treatment suppresses polyp formation in the Apc(Min/+) mouse and induces apoptosis in human colon adenocarcinoma cells via cyclic GMP.
    Shailubhai K; Yu HH; Karunanandaa K; Wang JY; Eber SL; Wang Y; Joo NS; Kim HD; Miedema BW; Abbas SZ; Boddupalli SS; Currie MG; Forte LR
    Cancer Res; 2000 Sep; 60(18):5151-7. PubMed ID: 11016642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intestinal and renal guanylin peptides system in hypertensive obese mice.
    Simões-Silva L; Moreira-Rodrigues M; Quelhas-Santos J; Fernandes-Cerqueira C; Pestana M; Soares-Silva I; Sampaio-Maia B
    Exp Biol Med (Maywood); 2013 Jan; 238(1):90-7. PubMed ID: 23479768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Guanylin and related peptides.
    Bełtowski J
    J Physiol Pharmacol; 2001 Sep; 52(3):351-75. PubMed ID: 11596856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal effects of uroguanylin and guanylin in vivo.
    Carrithers SL; Hill MJ; Johnson BR; O'Hara SM; Jackson BA; Ott CE; Lorenz J; Mann EA; Giannella RA; Forte LR; Greenberg RN
    Braz J Med Biol Res; 1999 Nov; 32(11):1337-44. PubMed ID: 10559834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Guanylin peptides: cyclic GMP signaling mechanisms.
    Forte LR; Freeman RH; Krause WJ; London RM
    Braz J Med Biol Res; 1999 Nov; 32(11):1329-36. PubMed ID: 10559833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guanylin, uroguanylin, and heat-stable euterotoxin activate guanylate cyclase C and/or a pertussis toxin-sensitive G protein in human proximal tubule cells.
    Sindiće A; Başoglu C; Cerçi A; Hirsch JR; Potthast R; Kuhn M; Ghanekar Y; Visweswariah SS; Schlatter E
    J Biol Chem; 2002 May; 277(20):17758-64. PubMed ID: 11889121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uroguanylin and guanylin peptides: pharmacology and experimental therapeutics.
    Forte LR
    Pharmacol Ther; 2004 Nov; 104(2):137-62. PubMed ID: 15518884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guanylin peptide family: history, interactions with ANP, and new pharmacological perspectives.
    Fonteles MC; do Nascimento NR
    Can J Physiol Pharmacol; 2011 Aug; 89(8):575-85. PubMed ID: 21815750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.